Korean J Physiol Pharmacol.  2010 Apr;14(2):91-97. 10.4196/kjpp.2010.14.2.91.

Pyrithione-zinc Prevents UVB-induced Epidermal Hyperplasia by Inducing HIF-1alpha

• Cho YS
• Lee KH
• Park JW

• KMID: 1457674
• DOI: http://doi.org/10.4196/kjpp.2010.14.2.91

Abstract

Epidermal keratinocytes overgrow in response to ultraviolet-B (UVB), which may be associated with skin photoaging and cancer development. Recently, we found that HIF-1alpha controls the keratinocyte cell cycle and thereby contributes to epidermal homeostasis. A further study demonstrated that HIF-1alpha is down-regulated by UVB and that this process is involved in UVB-induced skin hyperplasia. Therefore, we hypothesized that the forced expression of HIF-1alpha in keratinocytes would prevent UVB-induced keratinocyte overgrowth. Among several agents known to induce HIF-1alpha, pyrithione-zinc (Py-Zn) overcame the UVB suppression of HIF-1alpha in cultured keratinocytes. Mechanistically, Py-Zn blocked the degradation of HIF-1alpha protein in keratinocytes, while it did not affect the synthesis of HIF-1alpha. Moreover, the p21 cell cycle inhibitor was down-regulated after UVB exposure, but was robustly induced by Py-Zn. In mice repeatedly irradiated with UVB, the epidermis became hyperplastic and HIF-1alpha disappeared from nuclei of epidermal keratinocytes. However, a cream containing Py-Zn effectively prevented the skin thickening and up-regulated HIF-1alpha to the normal level. These results suggest that Py-Zn is a potential agent to prevent UVB-induced photoaging and skin cancer development. This work also provides insight into a molecular target for treatment of UVB-induced skin diseases.

Keyword

Ultraviolet; Skin; Hyperplasia; Hypoxia-inducible factor-1alpha; Pyrithione-zinc

MeSH Terms

Animals
Cell Cycle
Epidermis
Homeostasis
Hyperplasia
Keratinocytes
Mice
Skin
Skin Diseases
Skin Neoplasms

Figure

• 

  Fig. 1. Chemical structures of the test compounds. (A) Bafilomycin A1, (B) baicalein, (C) epigallocatechin 3-gallate (EGCG), (D) pyrithione-zinc (Py-Zn).

• 

  Fig. 2. HIF-1α levels in keratinocytes. (A) Effects of test compounds on HIF-1α expression. After HaCaT cells had been cultured to a cell density of 80 ∼ 100%, the cells were treated with various compounds for 4 hours. The cells were harvested and subjected to immunoblotting for HIF-1α and β-tubulin. Concentration: bafilomycin A1, 5 nM; baicalein, 200 μM; EGCG, 500 μM; pyrithione-zinc (Py-Zn), 2 μM. (B) HIF-1α levels after UVB irradiation. HaCaT cells were pretreated with bafilomycin A1 or Py-Zn at the concentrations indicated 2 hours before UVB irradiation, and transiently irradiated with 15 mJ/cm2 of UVB. Two hours later, HaCaT cells were harvested for immunoblotting. (C) Time course of Py-Zn-induced HIF-1α expression. HaCaT cells were treated with 2 μM Py-Zn, harvested at the indicated time, and then subjected to immunoblotting.

• 

  Fig. 3. Py-Zn stabilizes HIF-1α in keratinocytes. (A) HIF-1α protein stability. HaCaT cells were pretreated with DMSO vehicle or 2 μM Py-Zn for 1 hour, and then further treated with 60 μg/ml of cycloheximide (CHX). Cells were harvested at the indicated time, and HIF-1α levels were analyzed by immunoblotting. (B) Half-lives of HIF-1α proteins. The protein band densities were quantified using ImageJ and plotted as a function of time (first-order kinetics). (C) HIF-1α protein synthesis. HaCaT cells were treated with 60 μg/ml of cycloheximide for 30 min to remove remaining HIF-1α. To initiate HIF-1α synthesis, cells were washed with PBS and incubated in fresh media containing 10 μM MG132, and HIF-1α levels were determined at the indicated time by immunoblotting.

• 

  Fig. 4. p21 levels in keratinocytes. (A) Effect of Py-Zn on p21 expression in keratinocytes. HaCaT cells were treated with Py-Zn at the concentrations indicated for 4 hours and then harvested for immunoblotting. (B) Time course of Py-Zn-induced p21 expression. HaCaT cells were treated with 2 μM Py-Zn, harvested at the indicated time, and then subjected to immunoblotting with anti-p21 antiserum. (C) p21 levels after UVB irradiation. HaCaT cells were pretreated with Py-Zn at the indicated concentrations 2 hours before UVB irradiation, and irradiated with 15 mJ/cm2 of UVB. Two hours later, HaCaT cells were harvested for immunoblotting.

• 

  Fig. 5. In vivo effect of Py-Zn on UVB-induced skin hyperplasia. The back skin of each mouse was divided into four parts: the right lower quadrant for – UVB/ – Py-Zn (1), the right upper quadrant for –UVB/ + Py-Zn (2), the left lower quadrant for +UVB/–Py-Zn (3), the left upper quadrant for +UVB/+Py-Zn (4). Four mice were pretreated with PEG or 1% Py-Zn PEG cream 4 hours before UVB irradiation and then exposed to 460 mJ/cm2 of UVB once a day for four days. Back skins were excised, fixed, and embedded into paraffin blocks. (A) H&E staining of mouse skin. Skin specimens were obtained from 10 different sites per quadrant of each mouse and stained with H&E. (B) The thickness of the epidermis was analyzed at a magnification of 100×. The results were obtained from four mice (mouse 1∼4). ∗Denotes p<0.05 between two groups.

• 

  Fig. 6. In vivo effect of Py-Zn on UVB-induced HIF-1α suppression. (A) HIF-1α staining. The skin specimens were obtained as described in Fig. 5 and stained with anti-HIF-1α antibody. Nuclear HIF-1α was identified at a magnification of 100×. (B) Numbers of HIF-1α-positive keratinocytes. Three different slides per quadrant were stained and counted, and the data were collected from tissues of four mice (12 slides per group). ∗Denotes p<0.05 between two groups.

Reference

References

1. Melnikova VO, Ananthaswamy HN. Cellular and molecular events leading to the development of skin cancer. Mutat Res. 2005; 571:91–106.

2. Marrot L, Meunier JR. Skin DNA photodamage and its biological consequences. J Am Acad Dermatol. 2008; 58:S139–S148.

3. Ouhtit A, Muller HK, Davis DW, Ullrich SE, McConkey D, Ananthaswamy HN. Temporal events in skin injury and the early adaptive responses in ultraviolet-irradiated mouse skin. Am J Pathol. 2000; 156:201–207.

4. Lee JK, Kim JH, Nam KT, Lee SH. Molecular events associated with apoptosis and proliferation induced by ultraviolet-B radiation in the skin of hairless mice. J Dermatol Sci. 2003; 32:171–179.

5. El-Abaseri TB, Putta S, Hansen LA. Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor. Carcinogenesis. 2006; 27:225–231.

6. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem. 1995; 270:1230–1237.

7. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY, Semenza GL. Cellular and developmental control of O₂ homeostasis by hypoxia-inducible factor 1α. Genes Dev. 1998; 12:149–162.

8. Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE. HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J. 2004; 23:1949–1956.

9. Cho YS, Bae JM, Chun YS, Chung JH, Jeon YK, Kim IS, Kim MS, Park JW. HIF-1α controls keratinocyte proliferation by up-regulating p 21(WAF1/Cip1). Biochim Biophys Acta. 2008; 1783:323–333.

10. Cho YS, Kim CH, Park JW. Involvement of HIF-1α in UVB-induced epidermal hyperplasia. Mol Cells. 2009; 28:537–543.

11. Chun YS, Choi E, Kim GT, Lee MJ, Lee MJ, Lee SE, Kim MS, Park JW. Zinc induces the accumulation of hypoxia-inducible factor (HIF)-1α, but inhibits the nuclear translocation of HIF-1β, causing HIF-1 inactivation. Biochem Biophys Res Commun. 2000; 268:652–656.

12. Lim JH, Park JW, Kim MS, Park SK, Johnson RS, Chun YS. Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1α. Mol Pharmacol. 2006; 70:1856–1865.

13. Cho H, Lee HY, Ahn DR, Kim SY, Kim S, Lee KB, Lee YM, Park H, Yang EG. Baicalein induces functional hypoxia-inducible factor-1α and angiogenesis. Mol Pharmacol. 2008; 74:70–81.

14. Weinreb O, Amit T, Youdim MB. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (–)-epigallo-catechin-3-gallate. Free Radic Biol Med. 2007; 43:546–556.

15. Park SE, Park JW, Cho YS, Ryu JH, Paick JS, Chun YS. HIF-1α promotes survival of prostate cells at a high zinc environment. Prostate. 2007; 67:1514–1523.

16. Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxiainducible factor 1α is mediated by an O₂-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A. 1998; 95:7987–7992.

17. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 2004; 5:343–354.

18. Hudson CC, Liu M, Chiang GG, Otterness DM, Loomis DC, Kaper F, Giaccia AJ, Abraham RT. Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin. Mol Cell Biol. 2002; 22:7004–7014.

19. Lang KJ, Kappel A, Goodall GJ. Hypoxia-inducible factor-1α mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol Biol Cell. 2002; 13:1792–1801.

20. Arsham AM, Plas DR, Thompson CB, Simon MC. Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1α nor sufficient for HIF-1-dependent target gene transcription. J Biol Chem. 2002; 277:15162–15170.

21. Isaacs JS, Jung YJ, Mimnaugh EG, Martinez A, Cuttitta F, Neckers LM. Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway. J Biol Chem. 2002; 277:29936–29944.

22. Luo W, Zhong J, Chang R, Hu H, Pandey A, Semenza GL. Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1α but Not HIF-2α. J Biol Chem. 2010; 285:3651–3663.

23. Pierard-Franchimont C, Goffin V, Decroix J, Pierard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol. 2002; 15:434–441.

24. Bailey P, Arrowsmith C, Darling K, Dexter J, Eklund J, Lane A, Little C, Murray B, Scott A, Williams A, Wilson D. A doubleblind randomized vehicle-controlled clinical trial investigating the effect of ZnPTO dose on the scalp vs. antidandruff efficacy and antimycotic activity. Int J Cosmet Sci. 2003; 25:183–188.

25. Guthery E, Seal LA, Anderson EL. Zinc pyrithione in alcohol-based products for skin antisepsis: persistence of antimicrobial effects. Am J Infect Control. 2005; 33:15–22.